NO20071152L - Lysinbaserte forbindelser - Google Patents

Lysinbaserte forbindelser

Info

Publication number
NO20071152L
NO20071152L NO20071152A NO20071152A NO20071152L NO 20071152 L NO20071152 L NO 20071152L NO 20071152 A NO20071152 A NO 20071152A NO 20071152 A NO20071152 A NO 20071152A NO 20071152 L NO20071152 L NO 20071152L
Authority
NO
Norway
Prior art keywords
lysine
based compounds
cycloalkyl
alkyl
nao
Prior art date
Application number
NO20071152A
Other languages
English (en)
Norwegian (no)
Inventor
Brent Richard Stranix
Valerie Perron
Original Assignee
Ambrilia Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambrilia Biopharma Inc filed Critical Ambrilia Biopharma Inc
Publication of NO20071152L publication Critical patent/NO20071152L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/41Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20071152A 2004-08-02 2007-03-01 Lysinbaserte forbindelser NO20071152L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2004/001440 WO2006012725A1 (en) 2004-08-02 2004-08-02 Lysine based compounds

Publications (1)

Publication Number Publication Date
NO20071152L true NO20071152L (no) 2007-03-01

Family

ID=35786842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071152A NO20071152L (no) 2004-08-02 2007-03-01 Lysinbaserte forbindelser

Country Status (14)

Country Link
EP (2) EP1773763B1 (enExample)
JP (1) JP4579970B2 (enExample)
CN (1) CN1942436B (enExample)
AT (1) ATE417823T1 (enExample)
AU (2) AU2004322123B2 (enExample)
BR (1) BRPI0418651A (enExample)
CA (1) CA2560071C (enExample)
DE (1) DE602004018548D1 (enExample)
ES (2) ES2575871T3 (enExample)
IL (1) IL180958A0 (enExample)
MX (1) MX2007001278A (enExample)
NO (1) NO20071152L (enExample)
RU (1) RU2009139259A (enExample)
WO (1) WO2006012725A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
ES2575871T3 (es) 2004-08-02 2016-07-01 Ambrilia Biopharma Inc. Composiciones farmacéuticas que comprende un compuesto a base de lisina y un agente antiviral o antirretroviral VIH
EP1971615B1 (en) * 2005-11-30 2014-01-01 TaiMed Biologics, Inc. Lysme-based prodrugs of aspartyl protease inhibitors and processes for their preparation
JP2010502569A (ja) * 2006-07-17 2010-01-28 アンブリリア バイオファーマ インコーポレイテッド 薬物動態学の改善方法
EP2064177B1 (en) 2006-09-21 2017-04-05 TaiMed Biologics, Inc. Protease inhibitors
WO2009148600A2 (en) * 2008-06-06 2009-12-10 Concert Pharmaceuticals, Inc. Deuterated lysine-based compounds
EP2435037B1 (en) 2009-05-27 2014-11-12 Merck Sharp & Dohme Corp. Hiv protease inhibitors
US9079834B2 (en) 2010-10-28 2015-07-14 Merck Canada Inc. HIV protease inhibitors
EP2632908B1 (en) 2010-10-29 2016-05-25 Merck Canada Inc. Sulfonamides as hiv protease inhibitors
US9133157B2 (en) 2011-10-26 2015-09-15 Merck Canada Inc. HIV protease inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
CA2405151A1 (en) * 2000-04-07 2001-10-18 University Of Maryland, Baltimore Bile acid containing prodrugs with enhanced bioavailability
US6617310B2 (en) * 2000-07-19 2003-09-09 Bristol-Myers Squibb Pharma Company Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
JP2004517045A (ja) * 2000-08-18 2004-06-10 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 癌およびhivの治療用ベツリン酸誘導体のプロドラッグ
US6506786B2 (en) * 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
US6632816B1 (en) * 2002-12-23 2003-10-14 Pharmacor Inc. Aromatic derivatives as HIV aspartyl protease inhibitors
ES2575871T3 (es) 2004-08-02 2016-07-01 Ambrilia Biopharma Inc. Composiciones farmacéuticas que comprende un compuesto a base de lisina y un agente antiviral o antirretroviral VIH

Also Published As

Publication number Publication date
EP2165709B1 (en) 2016-03-16
CA2560071C (en) 2012-09-25
CA2560071A1 (en) 2006-02-09
EP1773763A4 (en) 2007-08-08
EP2165709A2 (en) 2010-03-24
IL180958A0 (en) 2007-07-04
JP4579970B2 (ja) 2010-11-10
EP1773763B1 (en) 2008-12-17
MX2007001278A (es) 2007-09-14
CN1942436B (zh) 2011-03-23
EP2165709A3 (en) 2010-06-23
DE602004018548D1 (de) 2009-01-29
RU2009139259A (ru) 2011-04-27
AU2004322123A1 (en) 2006-02-09
BRPI0418651A (pt) 2007-05-29
EP1773763A1 (en) 2007-04-18
AU2009230800A1 (en) 2009-11-19
WO2006012725A1 (en) 2006-02-09
AU2004322123B2 (en) 2009-08-13
CN1942436A (zh) 2007-04-04
HK1105406A1 (en) 2008-02-15
ES2575871T3 (es) 2016-07-01
ATE417823T1 (de) 2009-01-15
JP2007525527A (ja) 2007-09-06
ES2319996T3 (es) 2009-05-18

Similar Documents

Publication Publication Date Title
NO20071152L (no) Lysinbaserte forbindelser
HRP20130501T1 (xx) Mezonski pesticidi
NZ596107A (en) Antiviral compounds and methods
DE60208364D1 (de) Chinolinderivate mit einer azolylgruppe und chinazolinderivate
SE0300956D0 (sv) Stabilisatorblandningar
EP1795536A4 (en) PHOSPHORAMIDITE COMPOUND AND PROCESS FOR THE PREPARATION OF OLIGO RNA
ATE425983T1 (de) Siloxy substituierte metallocenkatalysatoren
DK2036943T3 (da) Compositions containing fluorine substituted olefins
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
ATE476173T1 (de) Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften
AR036472A1 (es) Derivados de azetidina, procedimientos para su preparacion y su empleo como agentes pesticidas
DK1447400T3 (da) Bicyklisk forbindelse
TW200600971A (en) Calixresorcinarene compounds, photoresist base materials, and compositions thereof
ATE504592T1 (de) Trehaloseverbindung und arzneimittel mit der verbindung
DE60223904D1 (de) Benzylaminanalogen
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
DE60238116D1 (de) Halogenierte chinolinderivate und mittel zur bekämpfung von ectoparasiten
DE60208477D1 (de) Wasser- und Öl-abweisende Zusammensetzung und daraus gebildeter Formkörper
ATE458035T1 (de) Schmutzlösungsmittel
EA200802273A1 (ru) Нейропротективные соединения и их применение
BR0206922A (pt) Compostos orgânicos
PT1004241E (pt) Agentes insecticidas e acaricidas de 2-aril-delta 2-1,3,4-(oxa e tia) diazolina
DK0787710T3 (da) Fluorpropenforbindelse, et insekticid indeholdende samme og et mellemprodukt til fremstilling deraf
DK1072601T3 (da) 4-Arylpiperidinderivater til behandling af pruritus
ATE377630T1 (de) Siliciumhaltige verbindung, zusammensetzung und isolierfilm

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application